SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jiri Koschel, Wolfgang Jost, Die Parkinson-Psychose, DNP - Der Neurologe und Psychiater, 2015, 16, 3, 49

    CrossRef

  2. 2
    Fabio Blandini, Marie-Therese Armentero, Dopamine receptor agonists for Parkinson's disease, Expert Opinion on Investigational Drugs, 2014, 23, 3, 387

    CrossRef

  3. 3
    Karla Eggert, Christian Öhlwein, Jan Kassubek, Martin Wolz, Andreas Kupsch, Andres Ceballos-Baumann, Reinhard Ehret, Udo Polzer, Fabian Klostermann, Johannes Schwarz, Gerd Fuchs, Wolfgang Jost, Anita Albert, Anja Haag, Anke Hermsen, Karin Lohmüller, Katrin Kuhn, Martina Wangemann, Wolfgang H. Oertel, Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD), Clinical Neuropharmacology, 2014, 37, 4, 116

    CrossRef

  4. 4
    S. Thobois, E. Lhommee, H. Klinger, C. Ardouin, E. Schmitt, A. Bichon, A. Kistner, A. Castrioto, J. Xie, V. Fraix, P. Pelissier, S. Chabardes, P. Mertens, J.-L. Quesada, J.-L. Bosson, P. Pollak, E. Broussolle, P. Krack, Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil, Brain, 2013, 136, 5, 1568

    CrossRef

  5. You have free access to this content5
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  6. 6
    Valerie Suski, Mark Stacy, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  7. 7
    Valerie Suski, Mark Stacy, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  8. 8
    D. Aarsland, C. Ballard, A. Rongve, M. Broadstock, P. Svenningsson, Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia, Current Neurology and Neuroscience Reports, 2012, 12, 5, 492

    CrossRef

  9. 9
    Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz, Cristina Sampaio, The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease, Movement Disorders, 2011, 26, S3
  10. 10
    Santiago Perez-Lloret, Olivier Rascol, Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease, CNS Drugs, 2010, 24, 11, 941

    CrossRef

  11. 11
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  12. 12
    Olivier Rascol, Jean-Philippe Azulay, Olivier Blin, Anne-Marie Bonnet, Christine Brefel-Courbon, Pierre Césaro, Philippe Damier, Bérengère Debilly, Frank Durif, Monique Galitzky, Jean-Marie Grouin, Sylvie Pennaforte, Gabriel Villafane, Sadek Yaici, Yves Agid, Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study, Movement Disorders, 2010, 25, 3
  13. 13
    Claire L. Tomlinson, Rebecca Stowe, Smitaa Patel, Caroline Rick, Richard Gray, Carl E. Clarke, Systematic review of levodopa dose equivalency reporting in Parkinson's disease, Movement Disorders, 2010, 25, 15
  14. 14
    Ala I Iaconi, Marliese A Zimmerman, Amit S Kulkarni, Rajesh Balkrishnan, Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature, Expert Opinion on Pharmacotherapy, 2008, 9, 2, 163

    CrossRef

  15. 15
    Olivier Rascol, Bruno Dubois, Alexandre Castro Caldas, Stephen Senn, Susanna Del Signore, Andrew Lees, Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study, Movement Disorders, 2006, 21, 12
  16. 16
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Early (Uncomplicated) Parkinson's Disease,